Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
To manage outcomes and costs, one in three (34%) firms now require employees to participate in lifestyle or clinical support programs before allowing clinical approval of GLP-1 agonists for weight loss
A few of these commenters asserted that CMS should work with HRSA to establish a repository with expanded scope that would support transparency across the 340B Program
We are beginning to see studies that address the maintenance of weight loss once the drug has been discontinued
Thyroid C-Cell Tumors: In mice and rats, tirzepatide (the active ingredient in Zepbound and Mounjaro) caused an increase in thyroid C-cell tumors, including medullary thyroid carcinoma (MTC)
Is There a Role for Colchicine in Acute Coronary Syndromes
US$ 24.22
US$ 29.22
US$ 20.32
US$ 26.33
US$ 25.02
US$ 25.21
US$ 27.89
